Apple Inc. is trying to delay a legal fight over allegedly stolen blood-oxygen monitoring technology in its latest watch so it can gain a more dominant share of the smartwatch market, medical-sensor maker Masimo Corp. said in a court filing late Monday.
Blood-oxygen monitoring is a key feature of the latest Apple Watch Series 6 announced on Sept. 15. Masimo and its spinoff Cercacor Laboratories Inc. had sued in January, accusing Apple of promising a working relationship only to steal secret information and hire away key employees, including Cercacor’s former chief technology officer and Masimo’s chief medical officer.
